Saltar al contenido
Merck

PROTBA

ProteoPrep® Blue Albumin & IgG Depletion Kit

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas

Acerca de este artículo

NACRES:
NA.56
UNSPSC Code:
41106500
Storage temp.:
2-8°C
Shipped in:
ambient
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


Quality Level

shipped in

ambient

storage temp.

2-8°C

Application

ProteoPrep® Blue Albumin & IgG Depletion Kit has been used:
  • to deplete serum samples from immunoglobulin (Ig) G and albumin
  • for albumin removal
  • for albumin and IgG removal
  • to deplete abundant plasma proteins for two-dimensional electrophoresis

Biochem/physiol Actions

ProteoPrep blue albumin depletion kit is designed to specifically remove albumin and IgG from 25 samples of human serum (25μL to 100μL) in preparation for two-dimensional electrophoresis (2DE). Albumin-depleted serum samples generated by this kit are in urea rather than salt-based buffers with little dilution, eliminating the need to precipitate the sample prior to performing 2DE.

Legal Information

ProteoPrep is a registered trademark of Merck KGaA, Darmstadt, Germany


signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Chronic 2 - Carc. 2 - Eye Dam. 1 - Flam. Liq. 3 - Repr. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Clase de almacenamiento

3 - Flammable liquids

wgk

WGK 3



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Zeyu Sun et al.
Theranostics, 9(4), 1200-1214 (2019-03-15)
Chronic HBV infection (CHB) can lead to acute-on-chronic liver failure (HBV-ACLF) characterized by high mortality. This study aimed to reveal ACLF-related proteomic alterations, from which protein based diagnostic and prognostic scores for HBV-ACLF were developed. Methods: Ten healthy controls, 16
Yiting Li et al.
Methods in molecular biology (Clifton, N.J.), 818, 81-96 (2011-11-16)
The development of a sensitive, specific, and non-invasive approach for cancer detection will facilitate early detection and, hence, improve the outcome of individuals with known cancer predispositions. Proteomic profiling of blood emerges to be a logical choice of such non-invasive
Hemangi S Bhonsle et al.
Molecular medicine reports, 7(2), 495-498 (2012-12-13)
Proteomic approaches aid in gaining a better understanding of the pathophysiology of diabetic complications. In view of this, differential protein expression in diabetic plasma samples was studied by a combination of proteomic and western blot analyses. Diabetic plasma samples were



Número de artículo de comercio global

SKUGTIN
PROTBA-1KT04061836686963